Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.24.23 (
MMP
)
4,246
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Arteriovenous access dysfunction is a major cause of morbidity for hemodialysis patients. The pathophysiology of arteriovenous fistula (AVF) maturation failure is associated with inflammation, impaired outward remodeling (OR) and intimal hyperplasia.
RP105
is a critical physiologic regulator of TLR4 signaling in numerous cell types. In the present study, we investigated the impact of
RP105
on AVF maturation, and defined cell-specific effects of
RP105
on macrophages and vascular smooth muscle cells (VSMCs). Overall,
RP105
-/-
mice displayed a 26% decrease in venous OR. The inflammatory response in
RP105
-/-
mice was characterized by accumulation of anti-inflammatory macrophages, a 76% decrease in pro- inflammatory macrophages, a 70% reduction in T-cells and a 50% decrease in
MMP
-activity. In vitro, anti-inflammatory macrophages from
RP105
-/-
mice displayed increased IL10 production, while MCP1 and IL6 levels secreted by pro-inflammatory macrophages were elevated. VSMC content in
RP105
-/-
AVFs was markedly decreased. In vitro,
RP105
-/-
venous VSMCs proliferation was 50% lower, whereas arterial VSMCs displayed a 50% decrease in migration, relative to WT. In conclusion, the impaired venous OR in
RP105
-/-
mice could result from of a shift in both macrophages and VSMCs towards a regenerative phenotype, identifying a novel relationship between inflammation and VSMC function in AVF maturation.
...
PMID:Deficiency of TLR4 homologue RP105 aggravates outward remodeling in a murine model of arteriovenous fistula failure. 2886 Jun 34